A Study of Merestinib (LY2801653) in Healthy Participants

Summary

The purpose of this study is to evaluate the effect of food on merestinib (standard meal and high-fat meal) compared to the fasted state. The study will also measure how much of the study drug gets into the blood stream and how long it takes the body to get rid of it. In addition, the tolerability of the study drug will be evaluated. Information about any side effects that may occur will also be collected. The study will last approximately 28 days. Screening is required within 28 days prior to the start of the study.

Timeline

Start

2016-05

Primary completion

2016-08

Completion

2016-08

Drugs

Indications

No indication recorded.